Skip to main content
Erschienen in:

06.11.2019 | Original Article

Increasing prevalence of multiple sclerosis in Tuscany, Italy

verfasst von: Daiana Bezzini, Monica Ulivelli, Elisa Gualdani, Matilde Razzanelli, Fabio Ferretti, Giuseppe Meucci, Paolo Francesconi, Mario A. Battaglia

Erschienen in: Neurological Sciences | Ausgabe 2/2020

Einloggen, um Zugang zu erhalten

Abstract

Background and rationale

An increase of prevalence and incidence of multiple sclerosis (MS) has been reported in several countries, especially taking into account a long-term evaluation. This increasing trend often reflects improved case identification and ascertainment due to the refinement of diagnostic criteria. The aim of this study was to update the prevalence rate of MS in Tuscany (central Italy) as of 2017, and to assess if there has been an increasing trend of prevalence in this Region considering a short period of analysis, from 2014 to 2017.

Methods

To capture prevalent cases, a case-finding algorithm based on administrative data, previously created and validated, was used. As data sources, we considered hospital discharge records, drug-dispensing records, disease-specific exemptions from copayment to health care, home and residential long-term care, and inhabitant registry.

Results

As of January 1, 2017, 7809 cases were identified, of which 69.4% were females and 30.6% were males. Considering temporal variation, an increasing trend was observed, with standardized rates rising from 189.2 in 2014 to 208.7 per 100,000 in 2017.

Conclusions

Results confirm that prevalence increases every year, probably mainly due to the difference between incidence and mortality, resulting in an increasing trend. Moreover, administrative data may accurately identify MS patients in a routinary way and monitor this cohort along disease care pathways.
Literatur
1.
Zurück zum Zitat Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG (2000) Multiple sclerosis. N Engl J Med. 343(13):938–952CrossRef Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG (2000) Multiple sclerosis. N Engl J Med. 343(13):938–952CrossRef
3.
Zurück zum Zitat Melcon MO, Correale J, Melcon CM (2014) Is it time for a new global classification of multiple sclerosis? J Neurol Sci. 344(1-2):171–181CrossRef Melcon MO, Correale J, Melcon CM (2014) Is it time for a new global classification of multiple sclerosis? J Neurol Sci. 344(1-2):171–181CrossRef
4.
Zurück zum Zitat Bezzini D, Pepe P, Profili F, Meucci G, Ulivelli M, Bartalini S, Battaglia MA, Francesconi P (2017) Multiple sclerosis spatial cluster in Tuscany. Neurol Sci. 38(12):2183–2187CrossRef Bezzini D, Pepe P, Profili F, Meucci G, Ulivelli M, Bartalini S, Battaglia MA, Francesconi P (2017) Multiple sclerosis spatial cluster in Tuscany. Neurol Sci. 38(12):2183–2187CrossRef
5.
Zurück zum Zitat Battaglia MA, Bezzini D (2017) Estimated prevalence of multiple sclerosis in Italy in 2015. Neurol Sci. 38(3):473–479CrossRef Battaglia MA, Bezzini D (2017) Estimated prevalence of multiple sclerosis in Italy in 2015. Neurol Sci. 38(3):473–479CrossRef
6.
Zurück zum Zitat Bezzini D, Battaglia MA (2017) Multiple sclerosis epidemiology in Europe. Adv Exp Med Biol. 958:141–159CrossRef Bezzini D, Battaglia MA (2017) Multiple sclerosis epidemiology in Europe. Adv Exp Med Biol. 958:141–159CrossRef
7.
Zurück zum Zitat Warren SA, Svenson LW, Warren KG (2008) Contribution of incidence to increasing prevalence of multiple sclerosis in Alberta, Canada. Multiple Sclerosis 14:872–879CrossRef Warren SA, Svenson LW, Warren KG (2008) Contribution of incidence to increasing prevalence of multiple sclerosis in Alberta, Canada. Multiple Sclerosis 14:872–879CrossRef
8.
Zurück zum Zitat Mayr WT, Pittock SJ, McClelland RL, Jorgensen NW, Noseworthy JH, Rodriguez M (2003) Incidence and prevalence of multiple sclerosis in Olmsted County, Minnesota, 1985–2000. Neurology 61:1373–1377CrossRef Mayr WT, Pittock SJ, McClelland RL, Jorgensen NW, Noseworthy JH, Rodriguez M (2003) Incidence and prevalence of multiple sclerosis in Olmsted County, Minnesota, 1985–2000. Neurology 61:1373–1377CrossRef
9.
Zurück zum Zitat Simpson S Jr, Blizzard L, Otahal P, van der Mei I, Taylor B (2011) Latitude is significantly associated with the prevalence of multiple sclerosis: a meta-analysis. J Neurol Neurosurg Psychiatry 82(10):1132–1141CrossRef Simpson S Jr, Blizzard L, Otahal P, van der Mei I, Taylor B (2011) Latitude is significantly associated with the prevalence of multiple sclerosis: a meta-analysis. J Neurol Neurosurg Psychiatry 82(10):1132–1141CrossRef
10.
Zurück zum Zitat Alla S, Pearson J, Debernard L, Miller D, Mason D (2014) The increasing prevalence of multiple sclerosis in New Zealand. Neuroepidemiology 42:154–160CrossRef Alla S, Pearson J, Debernard L, Miller D, Mason D (2014) The increasing prevalence of multiple sclerosis in New Zealand. Neuroepidemiology 42:154–160CrossRef
11.
Zurück zum Zitat Houzen H, Niino M, Hirotani M, Fukazawa T, Kikuchi S, Tanaka K, Sasaki H (2012) Increased prevalence, incidence, and female predominance of multiple sclerosis in northern Japan. J Neurol Sci. 323(1-2):117–122CrossRef Houzen H, Niino M, Hirotani M, Fukazawa T, Kikuchi S, Tanaka K, Sasaki H (2012) Increased prevalence, incidence, and female predominance of multiple sclerosis in northern Japan. J Neurol Sci. 323(1-2):117–122CrossRef
12.
Zurück zum Zitat Alroughani R, Ahmed SF, Behbahani R, Khan R, Thussu A, Alexander KJ, Ashkanani A, Nagarajan V, Al-Hashel J (2014) Increasing prevalence and incidence rates of multiple sclerosis in Kuwait. Mult Scler. 20(5):543–547CrossRef Alroughani R, Ahmed SF, Behbahani R, Khan R, Thussu A, Alexander KJ, Ashkanani A, Nagarajan V, Al-Hashel J (2014) Increasing prevalence and incidence rates of multiple sclerosis in Kuwait. Mult Scler. 20(5):543–547CrossRef
13.
Zurück zum Zitat AISM. Barometro della sclerosi multipla 2018 AISM. Barometro della sclerosi multipla 2018
14.
Zurück zum Zitat Granieri E, De Mattia G, Laudisi M, Govoni V, Castellazzi M, Caniatti L, Baldi E, Groppo E, Pugliatti M, Casetta I (2018) Multiple sclerosis in Italy: a 40-year follow-up of the prevalence in Ferrara. Neuroepidemiology. 51(3-4):158–165CrossRef Granieri E, De Mattia G, Laudisi M, Govoni V, Castellazzi M, Caniatti L, Baldi E, Groppo E, Pugliatti M, Casetta I (2018) Multiple sclerosis in Italy: a 40-year follow-up of the prevalence in Ferrara. Neuroepidemiology. 51(3-4):158–165CrossRef
15.
Zurück zum Zitat Solaro C, Ponzio M, Moran E, Tanganelli P, Pizio R, Ribizzi G, Venturi S, Mancardi GL, Battaglia MA (2015) The changing face of multiple sclerosis: prevalence and incidence in an aging population. Mult Scler. 21(10):1244–1250CrossRef Solaro C, Ponzio M, Moran E, Tanganelli P, Pizio R, Ribizzi G, Venturi S, Mancardi GL, Battaglia MA (2015) The changing face of multiple sclerosis: prevalence and incidence in an aging population. Mult Scler. 21(10):1244–1250CrossRef
16.
Zurück zum Zitat Caniglia-Tenaglia M, Guttmann S, Monaldini C, Manzaroli D, Volpini M, Stumpo M, Groppo E, Casetta I, Govoni V, Fonderico M, Pugliatti M, Granieri E (2018) Multiple sclerosis in the Republic of San Marino, Italian peninsula: an incidence and prevalence study from a high-risk area. Neurol Sci. 39(7):1231–1236CrossRef Caniglia-Tenaglia M, Guttmann S, Monaldini C, Manzaroli D, Volpini M, Stumpo M, Groppo E, Casetta I, Govoni V, Fonderico M, Pugliatti M, Granieri E (2018) Multiple sclerosis in the Republic of San Marino, Italian peninsula: an incidence and prevalence study from a high-risk area. Neurol Sci. 39(7):1231–1236CrossRef
17.
Zurück zum Zitat Grassivaro F, Puthenparampil M, Pengo M, Saiani M, Venturini M, Stropparo E, Perini P, Rinaldi F, Freddi N, Cadaldini M, Colledan L, Piccinno MG, Pedrazzoli E, Gallo P (2018) Multiple sclerosis incidence and prevalence trends in the province of Padua, Northeast Italy, 1965–2018. Neuroepidemiology. 52(1-2):41–46CrossRef Grassivaro F, Puthenparampil M, Pengo M, Saiani M, Venturini M, Stropparo E, Perini P, Rinaldi F, Freddi N, Cadaldini M, Colledan L, Piccinno MG, Pedrazzoli E, Gallo P (2018) Multiple sclerosis incidence and prevalence trends in the province of Padua, Northeast Italy, 1965–2018. Neuroepidemiology. 52(1-2):41–46CrossRef
18.
Zurück zum Zitat Nicoletti A, Patti F, Lo Fermo S, Messina S, Bruno E, Quattrocchi G, Laisa P, Cilia S, Mostile G, Marziolo R, Scillieri R, Maimone D, Zappia M (2011) Increasing frequency of multiple sclerosis in Catania, Sicily: a 30-year survey. Mult Scler. 17(3):273–280CrossRef Nicoletti A, Patti F, Lo Fermo S, Messina S, Bruno E, Quattrocchi G, Laisa P, Cilia S, Mostile G, Marziolo R, Scillieri R, Maimone D, Zappia M (2011) Increasing frequency of multiple sclerosis in Catania, Sicily: a 30-year survey. Mult Scler. 17(3):273–280CrossRef
19.
Zurück zum Zitat Bezzini D, Policardo L, Meucci G, Ulivelli M, Bartalini S, Profili F, Battaglia MA, Francesconi P (2016) Prevalence of multiple sclerosis in Tuscany (central Italy): a study based on validated administrative data. Neuroepidemiology. 46(1):37–42CrossRef Bezzini D, Policardo L, Meucci G, Ulivelli M, Bartalini S, Profili F, Battaglia MA, Francesconi P (2016) Prevalence of multiple sclerosis in Tuscany (central Italy): a study based on validated administrative data. Neuroepidemiology. 46(1):37–42CrossRef
20.
Zurück zum Zitat Esteve J, Benhamou E, Raymond L (1994) Statistical methods in cancer research, Volume IV. Descriptive epidemiology. IARC Sci Publ 128:1–302 Esteve J, Benhamou E, Raymond L (1994) Statistical methods in cancer research, Volume IV. Descriptive epidemiology. IARC Sci Publ 128:1–302
21.
Zurück zum Zitat Bezzini D, Policardo L, Profili F, Meucci G, Ulivelli M, Bartalini S, Francesconi P, Battaglia MA (2018) Multiple sclerosis incidence in Tuscany from administrative data. Neurol Sci. 39(11):1881–1885CrossRef Bezzini D, Policardo L, Profili F, Meucci G, Ulivelli M, Bartalini S, Francesconi P, Battaglia MA (2018) Multiple sclerosis incidence in Tuscany from administrative data. Neurol Sci. 39(11):1881–1885CrossRef
22.
Zurück zum Zitat Battaglia MA,Bezzini D,Ponzio M,Cipriani F. Mortality from multiple sclerosis in the region of Tuscany (central Italy). XLII Congress of the Italian Neurology Society. Torino, 22-25 October 2011 Battaglia MA,Bezzini D,Ponzio M,Cipriani F. Mortality from multiple sclerosis in the region of Tuscany (central Italy). XLII Congress of the Italian Neurology Society. Torino, 22-25 October 2011
25.
Zurück zum Zitat Pirastu R, Zona A, Ancona C, Bruno C, Fano V, Fazzo L, Iavarone I, Minichilli F, Mitis F, Pasetto R, Comba P (2011) Mortality results in SENTIERI project. Epidemiol Prev 35((5-6) Suppl. 4):103–106 Pirastu R, Zona A, Ancona C, Bruno C, Fano V, Fazzo L, Iavarone I, Minichilli F, Mitis F, Pasetto R, Comba P (2011) Mortality results in SENTIERI project. Epidemiol Prev 35((5-6) Suppl. 4):103–106
26.
Zurück zum Zitat Ponzio M, Gerzeli S, Brichetto G, Bezzini D, Mancardi GL, Zaratin P, Battaglia MA (2015) Economic impact of multiple sclerosis in Italy: focus on rehabilitation costs. Neurol Sci. 36(2):227–234CrossRef Ponzio M, Gerzeli S, Brichetto G, Bezzini D, Mancardi GL, Zaratin P, Battaglia MA (2015) Economic impact of multiple sclerosis in Italy: focus on rehabilitation costs. Neurol Sci. 36(2):227–234CrossRef
27.
Zurück zum Zitat Bargagli AM, Colais P, Agabiti N, Mayer F, Buttari F, Centonze D, Di Folco M, Filippini G, Francia A, Galgani S, Gasperini C, Giuliani M, Mirabella M, Nociti V, Pozzilli C, Davoli M (2016) Prevalence of multiple sclerosis in the Lazio region, Italy: use of an algorithm based on health information systems. J Neurol. 263(4):751–759CrossRef Bargagli AM, Colais P, Agabiti N, Mayer F, Buttari F, Centonze D, Di Folco M, Filippini G, Francia A, Galgani S, Gasperini C, Giuliani M, Mirabella M, Nociti V, Pozzilli C, Davoli M (2016) Prevalence of multiple sclerosis in the Lazio region, Italy: use of an algorithm based on health information systems. J Neurol. 263(4):751–759CrossRef
28.
Zurück zum Zitat Krysko KM, Ivers NM, Young J, O’Connor P, Tu K (2015) Identifying individuals with multiple sclerosis in an electronic medical record. Mult Scler. 21(2):217–224CrossRef Krysko KM, Ivers NM, Young J, O’Connor P, Tu K (2015) Identifying individuals with multiple sclerosis in an electronic medical record. Mult Scler. 21(2):217–224CrossRef
29.
Zurück zum Zitat Marrie RA, Yu N, Blanchard J, Leung S, Elliott L (2010) The rising prevalence and changing age distribution of multiple sclerosis in Manitoba. Neurology. 74(6):465–471CrossRef Marrie RA, Yu N, Blanchard J, Leung S, Elliott L (2010) The rising prevalence and changing age distribution of multiple sclerosis in Manitoba. Neurology. 74(6):465–471CrossRef
30.
Zurück zum Zitat Baldacci F, Policardo L, Rossi S, Ulivelli M, Ramat S, Grassi E, Palumbo P, Giovannelli F, Cincotta M, Ceravolo R, Sorbi S, Francesconi P, Bonuccelli U (2015) Reliability of administrative data for the identification of Parkinson’s disease cohorts. Neurol Sci. 36(5):783–786CrossRef Baldacci F, Policardo L, Rossi S, Ulivelli M, Ramat S, Grassi E, Palumbo P, Giovannelli F, Cincotta M, Ceravolo R, Sorbi S, Francesconi P, Bonuccelli U (2015) Reliability of administrative data for the identification of Parkinson’s disease cohorts. Neurol Sci. 36(5):783–786CrossRef
Metadaten
Titel
Increasing prevalence of multiple sclerosis in Tuscany, Italy
verfasst von
Daiana Bezzini
Monica Ulivelli
Elisa Gualdani
Matilde Razzanelli
Fabio Ferretti
Giuseppe Meucci
Paolo Francesconi
Mario A. Battaglia
Publikationsdatum
06.11.2019
Verlag
Springer International Publishing
Erschienen in
Neurological Sciences / Ausgabe 2/2020
Print ISSN: 1590-1874
Elektronische ISSN: 1590-3478
DOI
https://doi.org/10.1007/s10072-019-04090-0

Kompaktes Leitlinien-Wissen Neurologie (Link öffnet in neuem Fenster)

Mit medbee Pocketcards schnell und sicher entscheiden.
Leitlinien-Wissen kostenlos und immer griffbereit auf ihrem Desktop, Handy oder Tablet.

Neu im Fachgebiet Neurologie

Neuer FcRn-Blocker bremst Myasthenia gravis

Eine weitere Immuntherapie hat sich in einer Phase-3-Studie bei Myasthenia gravis bewährt: Mit dem Antikörper Nipocalimab gingen die Beschwerden bei Personen mit schlecht kontrollierter Erkrankung deutlich zurück.

Parkinsoninzidenz in Deutschland geht zurück

In Deutschland erkranken altersbezogen immer weniger Menschen an Morbus Parkinson: In den vergangenen 20 Jahren ist die Inzidenz um ein Fünftel gesunken. Das ergibt eine Analyse von AOK-Daten. Weshalb die Inzidenz zurückgeht, ist jedoch unklar.

„Wir wollen die Bedeutung von Gen- und Umwelteinflüssen besser verstehen“

Eine Mutation in einem einzelnen Gen kann bei Mäusen eine Art Bipolarstörung auslösen. PD Dr. Jan Deussing vom Max-Planck-Institut für Psychiatrie in München sieht in solchen Tiermodellen eine Möglichkeit, den Ursachen der Erkrankung auf den Grund zu gehen.

Suizidassistenz erhöht Suizidzahlen: Aktuelle Ergebnisse der geplanten S3-Leitlinie

Erstmals wird in Deutschland eine S3-Leitlinie zum Thema Suizidalität erarbeitet. Ziel ist es, die Versorgung in suizidalen Krisen durch einheitliche Standards zu verbessern. Erste Ergebnisse der bisherigen Leitlinienarbeit wurden auf dem DGPPN-Kongress vorgestellt.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.